Literature DB >> 2492609

Physical properties of the Creutzfeldt-Jakob disease agent.

T K Sklaviadis1, L Manuelidis, E E Manuelidis.   

Abstract

In this report, we present the first physical characterization of the Creutzfeld-Jakob disease agent. Preparations with high yields of infectivity (assayed infectious units) were obtained by a novel, gentle procedure in which initially sedimenting Gp34 ("prion" protein) was disaggregated by a variety of criteria with no subsequent loss of infectivity. Studies with this preparation indicate that most of the Creutzfeld-Jakob disease agent has both a viruslike size and density. In velocity sedimentation and isopycnic sucrose gradients, infectivity comigrated with nucleic acid-protein complexes of appreciable size.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492609      PMCID: PMC247817     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Three structural polypeptides coded for by minite virus of mice, a parvovirus.

Authors:  P Tattersall; P J Cawte; A J Shatkin; D C Ward
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

2.  Correct integration of retroviral DNA in vitro.

Authors:  P O Brown; B Bowerman; H E Varmus; J M Bishop
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

3.  Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA.

Authors:  C Sureau; J L Romet-Lemonne; J I Mullins; M Essex
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

4.  Isolation of a cDNA clone encoding the leader peptide of prion protein and expression of the homologous gene in various tissues.

Authors:  N K Robakis; P R Sawh; G C Wolfe; R Rubenstein; R I Carp; M A Innis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

Review 5.  Prions causing degenerative neurological diseases.

Authors:  S B Prusiner
Journal:  Annu Rev Med       Date:  1987       Impact factor: 13.739

6.  Purified prion proteins and scrapie infectivity copartition into liposomes.

Authors:  R Gabizon; M P McKinley; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

7.  Structure, sequence and expression of the hepatitis delta (delta) viral genome.

Authors:  K S Wang; Q L Choo; A J Weiner; J H Ou; R C Najarian; R M Thayer; G T Mullenbach; K J Denniston; J L Gerin; M Houghton
Journal:  Nature       Date:  1986 Oct 9-15       Impact factor: 49.962

8.  The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein (PrP).

Authors:  J Hope; L J Morton; C F Farquhar; G Multhaup; K Beyreuther; R H Kimberlin
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

9.  Assembly of influenza hemagglutinin trimers and its role in intracellular transport.

Authors:  C S Copeland; R W Doms; E M Bolzau; R G Webster; A Helenius
Journal:  J Cell Biol       Date:  1986-10       Impact factor: 10.539

10.  Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease.

Authors:  L Manuelidis; T Sklaviadis; E E Manuelidis
Journal:  EMBO J       Date:  1987-02       Impact factor: 11.598

View more
  29 in total

1.  The role of dimerization in prion replication.

Authors:  Peter Tompa; Gábor E Tusnády; Peter Friedrich; István Simon
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

Review 2.  The search for scrapie agent nucleic acid.

Authors:  J M Aiken; R F Marsh
Journal:  Microbiol Rev       Date:  1990-09

3.  Rapid chemical decontamination of infectious CJD and scrapie particles parallels treatments known to disrupt microbes and biofilms.

Authors:  Sotirios Botsios; Sarah Tittman; Laura Manuelidis
Journal:  Virulence       Date:  2015       Impact factor: 5.882

4.  Nuclease treatment results in high specific purification of Creutzfeldt-Jakob disease infectivity with a density characteristic of nucleic acid-protein complexes.

Authors:  T Sklaviadis; A Akowitz; E E Manuelidis; L Manuelidis
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 5.  Prion liposomes.

Authors:  R Gabizon; S B Prusiner
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

6.  Potential retroviral RNAs in Creutzfeldt-Jakob disease.

Authors:  G H Murdoch; T Sklaviadis; E E Manuelidis; L Manuelidis
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

7.  Vaccination with an attenuated Creutzfeldt-Jakob disease strain prevents expression of a virulent agent.

Authors:  L Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

8.  Prion diseases: dynamics of the infection and properties of the bistable transition.

Authors:  N Kellershohn; M Laurent
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

9.  The physical relationship between infectivity and prion protein aggregates is strain-dependent.

Authors:  Philippe Tixador; Laëtitia Herzog; Fabienne Reine; Emilie Jaumain; Jérôme Chapuis; Annick Le Dur; Hubert Laude; Vincent Béringue
Journal:  PLoS Pathog       Date:  2010-04-15       Impact factor: 6.823

10.  Quantitative recovery of scrapie agent with minimal protein from highly infectious cultures.

Authors:  Ru Sun; Ying Liu; He Zhang; Laura Manuelidis
Journal:  Viral Immunol       Date:  2008-09       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.